PHARMACOLOGICAL CHARACTERIZATION OF A HISTONE DEACETYLASE INHIBITOR AND TUMOR CELL-GROWTH INHIBITION PROPERTIES OF NEW BENZOFURANONE COMPOUNDS

被引：0
|
作者：
Blanquart, Christophe [1 ]
Francois, Manon [1 ]
Charrier, Cedric [2 ]
Bertrand, Philippe [2 ]
Gregoire, Marc [1 ]
机构：
[1] INSERM, U892, F-75654 Paris 13, France
[2] CNRS, Umr 6514, F-75700 Paris, France
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
Cancer; HDAC inhibitors; BRET;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S924 / S924
页数：1
相关论文
共 50 条
  • [1] Pharmacological Characterization of Histone Deacetylase Inhibitor and Tumor Cell-Growth Inhibition Properties of New Benzofuranone Compounds
    Blanquart, C.
    Francois, M.
    Charrier, C.
    Bertrand, P.
    Gregoire, M.
    CURRENT CANCER DRUG TARGETS, 2011, 11 (08) : 919 - 928
  • [2] Inhibition of tumor cell growth in vitro and in vivo by the histone deacetylase inhibitor oxamflatin.
    Plumb, JA
    Braidwood, L
    Finn, PW
    Williams, RJ
    Brown, R
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3800S - 3800S
  • [3] Inhibition of bladder tumour growth by histone deacetylase inhibitor
    Ozawa, Akira
    Tanji, Nozomu
    Kikugawa, Tadahiko
    Sasaki, Toyokazu
    Yanagihara, Yutaka
    Miura, Noriyoshi
    Yokoyama, Masayoshi
    BJU INTERNATIONAL, 2010, 105 (08) : 1181 - 1186
  • [4] Synthesis and Modeling of New Benzofuranone Histone Deacetylase Inhibitors that Stimulate Tumor Suppressor Gene Expression
    Charrier, Cedric
    Clarhaut, Jonathan
    Gesson, Jean-Pierre
    Estiu, Guillermina
    Wiest, Olaf
    Roche, Joelle
    Bertrand, Philippe
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (09) : 3112 - 3115
  • [5] Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase
    Butler, LM
    Webb, Y
    Agus, DB
    Higgins, B
    Tolentino, TR
    Kutko, MC
    LaQuaglia, MP
    Drobnjak, M
    Cordon-Cardo, C
    Scher, HI
    Breslow, R
    Richon, VM
    Rifkind, RA
    Marks, PA
    CLINICAL CANCER RESEARCH, 2001, 7 (04) : 962 - 970
  • [6] Selective growth inhibition of tumor cells by a novel histone deacetylase inhibitor, NVP-LAQ824
    Atadja, P
    Gao, L
    Kwon, P
    Trogani, N
    Walker, H
    Hsu, M
    Yeleswarapu, L
    Chandramouli, N
    Perez, L
    Versace, R
    Wu, A
    Sambucetti, L
    Lassota, P
    Cohen, D
    Bair, K
    Wood, A
    Remiszewski, S
    CANCER RESEARCH, 2004, 64 (02) : 689 - 695
  • [7] Cell growth inhibition and gene expression induced by the histone deacetylase inhibitor, trichostatin A, on human hepatoma cells
    Chiba, T
    Yokosuka, O
    Fukai, K
    Kojima, H
    Tada, M
    Arai, M
    Imazeki, F
    Saisho, H
    ONCOLOGY, 2004, 66 (06) : 481 - 491
  • [8] Pharmacodynamic response and inhibition of growth of human tumor xenografts by the novel histone deacetylase inhibitor PXD101
    Plumb, JA
    Finn, PW
    Williams, RJ
    Bandara, MJ
    Romero, MR
    Watkins, CJ
    La Thangue, NB
    Brown, R
    MOLECULAR CANCER THERAPEUTICS, 2003, 2 (08) : 721 - 728
  • [9] Phenolhexyl isothiocyanate, a new histone deacetylase inhibitor, can prevent tumor formation and inhibit leukemia cell growth in vivo.
    Lu, LL
    Ma, XD
    Becklemisheva, A
    Chaio, JW
    Liu, DL
    BLOOD, 2005, 106 (11) : 235B - 235B
  • [10] Enhancement of histone deacetylase inhibitor's efficacy with hydroxychloroquine via autophagy inhibition in pediatric tumor cell lines
    Cruz, Abigail Joy
    Bansal, Hima
    Tomlinson, Gail
    Bansal, Sanjay
    Weitman, Steven
    CANCER RESEARCH, 2016, 76
12345